首页> 美国卫生研究院文献>Cells >Identification of Novel Rare ABCC1 Transporter Mutations in Tumor Biopsies of Cancer Patients
【2h】

Identification of Novel Rare ABCC1 Transporter Mutations in Tumor Biopsies of Cancer Patients

机译:癌症患者肿瘤活检中新型罕见ABCC1转运蛋白突变的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The efficiency of chemotherapy drugs can be affected by ATP-binding cassette (ABC) transporter expression or by their mutation status. Multidrug resistance is linked with ABC transporter overexpression. In the present study, we performed rare mutation analyses for 12 transporters related to drug resistance (ABCA2, -A3, -B1, -B2, -B5, -C1, -C2, -C3, -C4, -C5, -C6, -G2) in a dataset of 18 cancer patients. We focused on rare mutations resembling tumor heterogeneity of ABC transporters in small tumor subpopulations. Novel rare mutations were found in , but not in the other ABC transporters investigated. Diverse mutations were found, including nonsense mutations causing premature stop codons, and compared with the wild-type protein in terms of their protein structure. Nonsense mutations lead to truncated protein structures. Molecular docking and heat map analyses of /MRP1 pointed out that Lys498* appeared in a separate cluster branch due to the large deletion, leading to a massive disruption in the protein conformation. The resulting proteins, which are nonfunctional due to nonsense mutations in tumors, offer a promising chemotherapy strategy since tumors with nonsense mutations may be more sensitive to anticancer drugs than wild-type -expressing tumors. This could provide a novel tumor-specific toxicity strategy and a way to overcome drug resistance.
机译:化疗药物的效率可能受ATP结合盒(ABC)转运蛋白表达或突变状态的影响。多药耐药性与ABC转运蛋白的过表达有关。在本研究中,我们对12种与耐药相关的转运蛋白(ABCA2,-A3,-B1,-B2,-B5,-C1,-C2,-C3,-C4,-C5,-C6, -G2)在18位癌症患者的数据集中。我们专注于类似于小肿瘤亚群中ABC转运蛋白肿瘤异质性的罕见突变。在研究的其他ABC转运蛋白中发现了新的罕见突变,但没有发现。发现了多种突变,包括导致过早终止密码子的无意义突变,并就其蛋白质结构与野生型蛋白质进行了比较。无意义的突变导致截短的蛋白质结构。 / MRP1的分子对接和热图分析指出,由于大量缺失,Lys498 *出现在单独的簇分支中,从而导致蛋白质构象大量破坏。由于肿瘤中的无义突变而导致的无功能的所得蛋白质提供了有希望的化学疗法策略,因为具有无义突变的肿瘤可能比表达野生型的肿瘤对抗癌药更敏感。这可以提供新颖的肿瘤特异性毒性策略和克服耐药性的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号